Advanced search
Publication Cover
Journal of Nutritional & Environmental Medicine Volume 10, 2000 - Issue 3
Journal homepage
6
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Chronic Fatigue Syndrome: How Far Have We Come?

Melvyn R. Werbach Member, Editorial Advisory Board, Journal of Nutritional & Environmental Medicine
Pages 181-188 | Published online: 13 Jul 2009

  • Fukada K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121(12): 9539.
  • Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990; 33:160-72.
  • White KP, Speechley M, Harth M, Ostbye T. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. Scand J Rheumatol 2000; 29(1): 44-51.
  • Yunus MB. Chronic fatigue syndrome and fibromyalgia syndrome: similarities and differences. The CFIDS Chronicle Physicians' Forum September, 1992: 53-8.
  • Dunstan RH, McGregor NR, Butt HL, Roberts TK. Biochemical and microbiological anomalies in chronic fatigue syndrome: the development of laboratory based tests and the possible role of toxic chemicals. J Nutr Environ Med 1999; 9: 97-108.
  • Evengard B, Schacterle RS, Komaroff AL. Chronic fatigue syndrome: new insights and old ignorance. J Intern Med 1999; 246: 455-69.
  • Johnson SK, DeLuca J, Natelson BH. Chronic fatigue syndrome: reviewing the research findings. Ann Behav Med 1999; 21(3): 258-71.
  • Moutschen M, Triffaux JM, Demonty J, et al. Pathogenic tracks in fatigue syndromes. Acta Clin Belg 1994; 49(6): 274-89.
  • Suhaldonik RJ, Peterson DL, O'Brien K, et al. Biochemical evidence for a novel low molecular weight 2-5A-dependent Rnase L in chronic fatigue syndrome. J Interferon Cytokine Res 1997; 17: 377-85.
  • Bates DW, Buchwald D, Lee J, et al. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med 1995; 155: 97-103.
  • Vojdani A, Choppa PC, Tagle C, et al. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol 1998; 22(4): 355-65.
  • Ablashi DV, Eastman HB, Owen CB, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000; 16(3): 179-91.
  • Galland L, Lee M, Bueno H, Heimowitz C. Giardia lamblia infection as a cause of chronic fatigue. J Nutr Med 1990; 1: 27-31.
  • Dunstan RH, Donohoe M, Taylor W, et al. A preliminary investigation of chlorinated hydrocarbons and chronic fatigue syndrome. Med J Aust 1995; 163: 294-7.
  • Mersch U, Lowenthal RM, Coleman D. Lead poisoning masquerading as chronic fatigue syndrome. Letter to the editor. Lancet 1996; 347: 1193.
  • Behan PO. Chronic fatigue syndrome as a delayed reaction to chronic low-dose organophosphate exposure. J Nutr Environ Med 1996; 6: 341-50.
  • Jaffer S, Davis D. Factors suggestive of a link between CO and ME. Letter to the editor. J Nutr Environ Med 1998; 8: 367-71.
  • Lobley RH. The role of food intolerance in chronic fatigue syndrome. In: Hyde BM, ed. The clinical and scientific basis of myalgic encephalomyelitis/chronic fatigue syndrome. Ottawa: The Nightingale Research Foundation, 1992, 521-38.
  • Rowe AH. Allergic fatigue and toxemia. Ann Allergy 1959; 17: 9-18.
  • Matthews SB, Campbell AK. When sugar is not so sweet. Lancet 2000; 355: 1330.
  • Manu P, Matthews DA, Lane TJ. Food intolerance in patients with chronic fatigue. Int J Eat Disord 1993; 13(2): 203-9.
  • Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994; 154(18): 2049-53.
  • Ojo-Amaize EA, Conley EJ, Peter JB. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clin Infect Dis 1994; 18(Suppl 1): S157-9.
  • Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85(2): 692-6.
  • Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Psychosom Res 1990; 34: 665-73.
  • Cleare AJ, Heap E, Malhi GS, et al. Low-dose hydrocortisone in chronic fatigue syndrome: a randomized crossover trial. Lancet 1999; 353: 455-8.
  • Scott LV, The J, Reznek R, et al. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology 1999; 24(7): 759-68.
  • Zeitoun MM, Hassan AI, Hussein ZM, et al. Adrenal glucocorticoid function in acute viral infections in children. Acta Paediatr Scand 1973; 62: 608-14.
  • Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994; 15:504-11.
  • Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325: 606-12.
  • Dobbins JB, Natelson BH, Brassloff I, Drastal S, Sisto S-A. Physical, behavioral, and psychological risk factors for chronic fatigue syndrome: A central role for stress? J Chronic Fatigue Syndrome 1995; 1: 43-58.
  • Jacobson W, Saich T, Borysiewicz LK, et al. Serum folate and chronic fatigue syndrome. Neurology 1993; 121: 953-9.
  • Heap LC, Peters TJ, Wessely S. Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med 1999; 92: 183-5.
  • Grant JE, Veldee MS, Buchwald D. Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome. J Am Diet Assoc 1996; 96: 383-6.
  • Regland B, Andersson M, Abrahamsson L, et al. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol 1997; 26: 301-7.
  • Bralley JA, Lord RS. Treatment of chronic fatigue syndrome with specific amino acid supplementation. J Appl Nutr 1994; 74-8.
  • Yunus MB, Dailey JW, Aldag JC, et al. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 1992; 90-4.
  • Campos Y, Huertas R, Lorenzo G, et al. Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 1993; 16: 150-3.
  • Judy W. Presentation to the 37th Annual Meeting, American College of Nutrition, October 13, 1996.
  • Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990; 82: 209-16.
  • Eaton KK, Hunnisett A. Abnormalities in essential amino acids in patients with chronic fatigue syndrome. J Nutr Med 1991; 2: 369-75.
  • Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev 2000; 5(2): 93-108.
  • Wesnes KA, Raleni RA, Hefting NR, et al. The cognitive, subjective, and physical effects of a Ginkgo biloba/Panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharm Bull 1997; 33(4): 677-83.
  • Baschetti R. Chronic fatigue syndrome and liquorice. Letter to the editor. N Z Med J 1995: 156-7.
  • British Society for Allergy and Environmental Medicine with the British Society for Nutritional Medicine Subcommittee on Allergy Practice. Effective allergy practice: a document on standards of care and management for the allergy patient. J Nutr Environ Med 1995; 5: 79-104.
  • Carette S, Bell M J, Reynolds WJ. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis Rheum 1994; 1: 32.
  • Sharpe M. Cognitive behaviour therapy for chronic fatigue syndrome: efficacy and implications. Am J Med 1998; 105: 104-9.
  • Strayer DR, Carter WA, Brodsky I, et al. A controlled clinical trial with a specially configured RNA drug, poly[I].poly[-C12U], in chronic fatigue syndrome. Clin Infect Dis 1994; 18(Suppl 1): S88-95.
  • McKenzie R, O'Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome. JAMA 1998; 280: 1061-6.
  • Jefferies, W McK. Safe Uses of Cortisone. Springfield, Illinois, Charles C. Thomas, 1981.
  • Jefferies, W McK. Low-dosage glucocorticoid therapy: an appraisal of its safety and mode of action in clinical disorders, including rheumatoid arthritis. Arch Intern Med 1967; 119: 265-78.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.